Ultima Genomics
Labcorp, Ultima Genomics Collaborate on NGS-Based Cancer Testing
Labcorp will use Ultima's UG100 sequencer and ppmSeq technology for minimal residual disease testing in patients with early-stage solid tumors.
Quest Diagnostics, Ultima Genomics Team Up to Develop Clinical Sequencing Tests
Quest will use Ultima's high-throughput sequencing tech to develop MRD detection tests in solid tumors and potentially for rare disease diagnosis.
Ultima Genomics, Exact Sciences Ink Long-Term Sequencing Supply Agreement
In conjunction with the deal, Exact Sciences also made an investment of undisclosed size into Ultima Genomics and joined the firm’s early-access program.